Tuesday, November 10, 2026
28.2 C
Bengaluru

What’s the Mood of Indian Pharma? A Poll by MedicinMan

We are in the middle of huge crisis and uncertainty. The Covid-19 crisis is taking a toll on Indian Pharma Leaders. Many leaders are not sure - what is of critical importance at this time? What are they are supposed to do and how they are supposed to do it? There are enormous challenges that majority of leaders have not faced before.

  • Many leaders had to take a pay-cut, downsize their teams, and deliver bad news up and down the organization.
  • Working from home for months and feeling stressed because there is no light at the end of the tunnel.
  • What can you do to stay focused and upbeat during this prolonged uncertain time?
  • How can you learn to reframe the situation that you are facing?
  • Who can you vent your frustration and feelings to? And, what can you do to recharge when most of your usual outlets are not available?

Leading effectively — especially during a crisis, needs emotional maturity and patience. If you can’t retain your cool and composure in the face of frustration and adversity, you won’t be able to keep others in your team, calm.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img